2 MATERIAL AND METHODS
This prospective, single-center, randomized trial was registered with the Chinese Clinical Trial Registry as ChiCTR 2000031338 and conducted at Beijng Anzhen Hospital. All patients provided written informed consent. The trial was conducted in compliance with the International Conference on Harmonisation and the Declaration of Helsinki. This study was approved by the Beijing Anzhen Hospital Medical Ethics Committee.